Liver X receptor modulators: a review of recently patented compounds (2007 - 2009). - Wikidata - wikimedia - TriplyDB

Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).

Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).

http://www.wikidata.org/entity/Q37714905

about

Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo Cholesterol in the retina: the best is yet to come.Development of therapeutic polymeric nanoparticles for the resolution of inflammation.Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.Pathways of cholesterol homeostasis in mouse retina responsive to dietary and pharmacologic treatments.TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells.Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug Conjugate Liver X receptors and fat cell metabolism.Targeting liver X receptors in human health: deadlock or promising trail?Practical strategies for modulating foam cell formation and behavior.Resveratrol modulates ATPase activity of liposome-reconstituted ABCG1.Ouabagenin is a naturally occurring LXR ligand without causing hepatic steatosis as a side effect.The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis.

P2860

Q28235379-A5A304CC-1022-4D81-BE20-78DF961E1CEE Q33758267-D4489930-0ADF-4FB8-A7E7-9F339B07987A Q34160852-B1B79CFB-0AFD-4552-BB27-1CFFC2C4AEEB Q34521175-99D110EA-98B8-4C8E-B069-1771902ECB4E Q34757496-9E66CD73-61C2-485B-985E-31AA702EA0B9 Q35560513-E7210DA3-1BDF-46E8-92CE-56AF748385F6 Q36296686-887B0F0D-9A2B-411F-9602-6F97AB443D4D Q36460531-0F280CC7-2263-43FC-8C8F-D85EFC90FB73 Q37825904-3D93BC4B-EB04-45B5-ABEF-2CD27214F0AB Q38261037-E25C0263-4705-4954-A662-7FCCDDA3E236 Q42710681-4B79E252-C23F-43C5-B528-DCA7625BEBC0 Q48112560-E60492D9-C735-4E8D-A992-A9C707407622 Q54988933-4D7C645D-79A7-4349-9768-D8D6BBC39BA5

P2860

Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).

http://www.wikidata.org/entity/Q37714905

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).

@en

Liver X receptor modulators: a review of recently patented compounds

@nl

type

label

Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).

@en

Liver X receptor modulators: a review of recently patented compounds

@nl

prefLabel

Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).

@en

Liver X receptor modulators: a review of recently patented compounds

@nl

P1433

Q37714905-300EE837-F83E-4D68-8697-287DF7DC940E

P1476

Q37714905-419A649F-E612-45D3-BBC1-18EBD9F46ECA

P2093

Q37714905-627F19E7-1D15-4EF3-8B67-066968C7E641

Q37714905-904001DF-5503-4ED1-AE6E-3BF46FF9176A

Q37714905-D1381726-D937-4669-B448-0C03AD0A0BC2

P2860

Q37714905-04587929-0C18-4363-BAAE-0D685E524B67

Q37714905-05C0ECAB-81C5-45E2-BF27-E5E81ED4FB51

Q37714905-0A1DB4EC-4334-4257-9F0F-2A7BE77ABFF2

Q37714905-0CC07D21-FC37-4974-9242-3B7BAAD04095

Q37714905-0EF605B0-B7D4-4985-8D29-876B09653EC3

Q37714905-10CA4321-0A43-43A1-89EC-5A0B12A4A17C

Q37714905-1FB47133-AAD2-415A-BB82-1E8775098816

Q37714905-2BA34BC0-8DB7-4795-B793-8FEAA3BF63E6

Q37714905-3012F7EE-BF5A-4F85-AB90-F63C305D6D83

Q37714905-33DA1E3E-C91A-40E7-8F58-B1642FB855AE

P304

Q37714905-036954D7-F8F9-4594-BA3C-A437B6089E58

P31

Q37714905-CD04FA4E-4499-4F71-BDF7-6670D32F8E56

P356

Q37714905-ACDC4E8A-10E8-4CB6-86E9-ACE013EA458B

P407

Q37714905-A32F4935-41AF-4E1E-8303-7B05AA66A2E6

P433

Q37714905-86D96FC5-0038-4AD9-BCEA-51D1144AD75A

P478

Q37714905-17E6DCDE-3339-4306-B28A-35EA9C30D5EF

P577

Q37714905-7875B579-1A6D-4C5E-B7A1-8FA15C090961

P698

Q37714905-4E59E231-975A-433D-960B-9451225B7CA9

P921

Q37714905-40543B51-AB70-4972-9C20-0E0B8D61FAC3

P356

13543771003621269

P1433

Expert Opinion on Therapeutic Patents

P1476

Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).

@en

P2093

Valentina Molteni

http://www.w3.org/2001/XMLSchema#string

Vince Yeh

http://www.w3.org/2001/XMLSchema#string

Xiaolin Li

http://www.w3.org/2001/XMLSchema#string

P2860

Role of LXRs in control of lipogenesis

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

ApoE promotes the proteolytic degradation of Abeta

Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia

X-ray crystal structure of the liver X receptor beta ligand binding domain: regulation by a histidine-tryptophan switch

4-(3-Aryloxyaryl)quinoline sulfones are potent liver X receptor agonists

Alzheimer's disease: the cholesterol connection

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors

Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice

P304

535-562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543771003621269

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20302451

http://www.w3.org/2001/XMLSchema#string

P921